Literature DB >> 32946858

Relation of Interatrial Block to Cognitive Impairment in Patients ≥ 70 Years of Age (From the CAMBIAD Case-control Study).

Cristian Herrera1, Vanesa Bruña1, Pedro Abizanda2, Pablo Díez-Villanueva3, Francesc Formiga4, Rosa Torres5, José Carreras6, Rocio Ayala7, F Javier Martin-Sánchez8, Antoni Bayés-Genis9, Roberto Elosua10, Antonio Bayés-de-Luna11, Manuel Martínez-Sellés12.   

Abstract

The association between atrial fibrillation, stroke, and interatrial block (IAB) (P-wave duration ≥120 ms) is well recognized, particularly in the case of advanced IAB. We aimed to assess the association of IAB with mild cognitive impairment. Advanced Characterization of Cognitive Impairment in Elderly with Interatrial Block was a case-control multicenter study, conducted in subjects aged ≥70 years in sinus rhythm without significant structural heart disease. Diagnosis of mild cognitive impairment was performed by an expert geriatrician, internist, or neurologist in the presence of changes in cognitive function (Mini Mental State Examination score 20 to 25) without established dementia. A total of 265 subjects were included. Mean age was 79.6 ± 6.3 years and 174 (65.7%) were women; there were 143 cases with mild cognitive impairment and 122 controls with normal cognitive function. Compared with controls, cases had longer P-wave duration (116.2 ± 13.8 ms vs 112.5 ± 13.3 ms, p = 0.028), higher prevalence of IAB (73 [51.0%] vs 38 [31.1%], p = 0.001), higher prevalence of advanced IAB (28 [19.6%] vs 10 [8.2%], p = 0.002), and higher MVP ECG risk score (2.7 ± 1.4 vs 2.2 ± 1.3, p = 0.004). IAB was independently associated with mild cognitive impairment, both for partial (odds ratio 2.0, 95% CI: 1.1 to 3.9) and advanced IAB (odds ratio 2.8, 95% CI: 1.1 to 6.7). In conclusion, in subjects aged ≥70 years without significant structural heart disease, IAB is independently associated with mild cognitive impairment. This association is stronger in the case of advanced IAB.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32946858     DOI: 10.1016/j.amjcard.2020.09.008

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  2 in total

1.  Interatrial block, atrial fibrillation, and thrombotic events in COVID-19.

Authors:  Manuel Martínez-Sellés
Journal:  Eur J Clin Invest       Date:  2022-05-04       Impact factor: 5.722

Review 2.  Atrial cardiopathy and cognitive impairment.

Authors:  Sarah J Myers; Amado Jiménez-Ruiz; Luciano A Sposato; Shawn N Whitehead
Journal:  Front Aging Neurosci       Date:  2022-07-22       Impact factor: 5.702

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.